European Pharmaceutical Review

MAY 14, 2024

This cash injection will create more than 500 jobs and “significantly strengthen” France’s present and future ability to control the full production process of essential medicines, the company stated. An investment of €250 million will used to build Europe’s largest flu vaccine production unit in Val de Reuil.

Vaccines 98

Vaccines Packaging Diabetes 98

Express Pharma

DECEMBER 11, 2023

The COVID-19 pandemic also highlighted the vital role of the cold chain in ensuring patient safety during vaccine distribution. And, with India’s vaccine, biopharma, and clinical trials market projected to grow in double-digits, there will be an increasing demand for efficient cold chain facilities. billion in 2022.

Packaging 115

Packaging Vaccines 115

European Pharmaceutical Review

AUGUST 18, 2022

Merck (MSD outside of the US and Canada) has entered into a collaboration agreement with Orna Therapeutics to discover, develop and commercialise multiple programmes of engineered circular RNA (oRNA) therapies, including vaccines and therapeutics in the areas of infectious disease and oncology.

Vaccines 98

Vaccines Research Laboratories Packaging 98

pharmaphorum

DECEMBER 13, 2021

It started with two Covid-19 vaccines – 2021 is the year interest in mRNA therapeutics boomed, reports Katrina Megget. The Covid-19 pandemic showed what could be done with resources and collaboration to accelerate the development of vaccines. There are multiple other mRNA vaccines that are being developed.

Vaccines 105

Vaccines Packaging 105

Express Pharma

JUNE 28, 2024

With a focus on redefining the pharmaceutical industry in the post-COVID era, PharmaLytica 2024 offered a platform for stakeholders to engage in discussions covering the full spectrum of pharma machinery and packaging, lab analytical and cleanroom solutions, and pharmaceutical ingredients. trillion, with Turkey ranking 21st.

Packaging 105

Packaging Biosimilars Labelling Vaccines 105

Express Pharma

AUGUST 20, 2023

Both Johnson & Johnson and Pfizer criticised the changes by referencing the positive role of patents in incentivising their vaccine production during the COVID-19 pandemic. Firstly, the proposal has not been finalised, and the ultimate version presented by the EC after next year’s European elections may include industry concessions.

Packaging 98

Packaging Vaccines Drug Development 98

Pharmaceutical Technology

JULY 29, 2022

Pfizer (New York, New York) and Moderna’s (Cambridge, Massachusetts) Omicron-specific Covid-19 vaccines are in late-stage development, have demonstrated good efficacy against the variant and will likely be available to the public later this year to provide an additional booster and increase demand for injectable manufacturing.

Vaccines 52

Vaccines Packaging Immunity Immunization 52

pharmaphorum

JANUARY 28, 2021

The Covid-19 pandemic has put further pressure on clinical trial suppliers to be fleet of foot in getting products dispatched when a new patient is recruited, as studies for vaccines have been set up and run at unprecedented speed. . To find out more about the webinar and to register, visit [link] .

Labelling 52

Labelling Packaging Vaccines 52

Pharmaceutical Technology

AUGUST 30, 2022

Brazilian pharma production sites are involved in Covid-19 vaccine and therapy manufacture. Oswaldo Cruz Foundation will package the drug in its facility in Rio de Janeiro before supplying it to the Brazilian public health system; the company is also involved in clinical trials for the drug’s possible use as Covid-19 prophylaxis.

Vaccines 78

Vaccines Pharmaceutical Manufacturing Packaging 78

European Pharmaceutical Review

MARCH 1, 2023

Nowhere is this more publicly evident than in the development, regulatory approval, and efficacious use of mRNA‑based vaccines for COVID-19. Beyond the high-profile COVID-19 vaccines, mRNA therapeutics are crucial in applications such as protein replacement therapies and regenerative medicine.

Vaccines 111

Vaccines Packaging 111

pharmaphorum

APRIL 11, 2022

Medicines and vaccines are among the most powerful interventions that can help improve quality of life for people across the world. Such therapies present significant challenges to our current regulatory and access processes, but these are challenges we must overcome if patients are to benefit.

Pharmaceutical Companies 115

Pharmaceutical Companies Pharmaceutical Companies Vaccines Packaging 115

pharmaphorum

MAY 27, 2022

Once stakeholders are confident that technologies are adequately validated, selection based on scientific and ethical considerations can be presented to regulators in accordance with applicable legal and regulatory frameworks. As a Non-Clinical Assessor at MHRA he assessed non-clinical data packages for new and generic medicines.

Packaging 80

Packaging Generic Medicine Communication Hospitals 80

pharmaphorum

OCTOBER 12, 2022

Other key areas will be microneedle vaccines and transdermal patches for management of chronic disease. BENEFITS OF ATTENDING: Engage with senior industry opinion leaders presenting their experiences and case studies in innovative device design and advanced drug product formulation. Primary Packaging Material Designers.

Packaging 40

Packaging Vaccines Drug Development 40

FADIC

MARCH 22, 2024

Symptoms Common cold symptoms include a runny or stuffy nose, sneezing, sore throat, mild cough, and low-grade fever (if present). Vaccination No Vaccine for the common cold Vaccines are available to help prevent the flu. Follow the instructions: Read and follow the instructions on the packaging carefully.

Immunity 100

Immunity Immunization Dosage Packaging 100

pharmaphorum

JANUARY 17, 2022

SMi presents its 16th annual Parallel Trade conference on the 21st and the 22nd March 2022. SMi Group offer direct access to key decision makers through tailored sponsorship and exhibitor packages. There will be highlights of Professor Stefan Enchelmaier’s work and case studies, focusing on re-packaging and intellectual property.

Packaging 52

Packaging Vaccines 52

epicur

JULY 12, 2023

The unit-dose blister packaging offers key advantages and safer handling for veterinary staff and pet owners. DNA from the tissue is then extracted and sequenced to identify the gene mutations present and to determine the proteins produced as a result of those specific mutations. Learn more about the benefits.

Immunity 85

Immunity Chemotherapy Immunization Vaccines 85

Pharmaceutical Technology

DECEMBER 9, 2022

Solvias has extensive experience with analytical method development and testing for mRNA-based vaccines as well as monograph testing of excipients and APIs according to Ph Eur or USP. Assays to support mRNA-based Covid-19 vaccines. However, messenger RNA (mRNA) based vaccines present particular analytical challenges.

Vaccines 52

Vaccines Biosimilars Compounding Packaging 52

Pharmaceutical Technology

FEBRUARY 3, 2023

With scientists fervently developing mRNA vaccines, nucleic acid therapeutics, and viral vector-based gene therapies, clinicians are set to have a growing number of tools available to treat a wide range of conditions, from infectious diseases to genetic disorders and more. Two-Plasmid Packaging System for Recombinant Adeno-Associated Virus.

Communication 97

Communication Dosage Packaging Vaccines 97

PharmaShots

JUNE 1, 2023

PDC*line is much more potent than conventional dendritic cell-based vaccines in priming and boosting antitumor antigen-specific cytotoxic T-cells, including the T-cells specific for neoantigens, and is synergistic with checkpoint inhibitors. We presented our first results this year at ESMO and ESMO-IO.

Immunity 40

Immunity Immunization Vaccines Health and Personal Care Stores 40

Pharmaceutical Technology

NOVEMBER 9, 2022

At the start of 2022 alone, BenevolentAI partnered with AstraZeneca and Exscientia joined forces with Sanofi in deals designed to combine the efficiency-maximising power of AI-driven start-ups with the scale and reach of vaccine producing conglomerates. Digital transformation is permeating the entire pharmaceutical supply chain.

Vaccines 52

Vaccines Packaging Communication 52

Quality Matters

JUNE 14, 2023

Standards ensure quality The USP presentation to the panel included an overview of USP's GDP-related milestones and current approach, which focuses on risks and mitigation strategies for the storage and transportation of drug products. Also open for public comments is new General Chapter Qualification of Storage Areas.

Dosage 52

Dosage Packaging Documentation Hospitals 52

PharmaShots

MARCH 9, 2023

We are esteemed and elated to present a list of the 20 women who have excelled in reaching the summit of excellence, arranged alphabetically Total experience: 16 yrs. Present company and time period: Pfizer (2 yrs.) Present company and time period: Sensium Healthcare (6 yrs. Present company and time period: Pfizer (26 yrs.)

Clinical Pharmacology 40

Clinical Pharmacology Immunity Immunization Pharmaceutical Companies 40

Pharma in Brief

JANUARY 9, 2022

In response to the COVID-19 pandemic, in 2020, the Minister of Health signed interim orders designed to streamline the process to authorize the importation or sale of drugs, vaccines, and medical devices used to diagnose, treat, mitigate, or prevent COVID-19. Proposed amendments to the PM(NOC) Regulations were also introduced in 2021.

Documentation 52

Documentation Labelling Vaccines Packaging 52

Quality Matters

MAY 23, 2023

This alone can present serious risks to patients’ health and public health. They include the potential for substandard packaging and shipment, falsification of product information and markings, detection of undeclared chemicals, high variability of quality across samples, and payment for orders being subject to fraud.

Online Pharmacies 52

Online Pharmacies Controlled Substances Packaging Communication 52

PharmaShots

APRIL 25, 2023

This year Roche has secured the top position with a total R&D Expenditure of $15.20B, followed by Johnson & Johnson and AstraZeneca PharmaShots presents the Top 20 RNAi therapeutic companies based on their R&D Expenditure in the year 2022 R&D Expenditure: $43.1M R&D Expenditure: $6.6B R&D Expenditure: $6.6B

HIV Treatment and Prevention Agents 40

HIV Treatment and Prevention Agents Diabetes Packaging Immunity 40

Express Pharma

JANUARY 12, 2024

Initiatives such as Ayushmaan Bharat Digital Mission (“ADBDM”), CoWIN (a digital vaccine delivery platform), health registry, and telemedicine, highlight the government’s strong emphasis on digitisation of health in India. This can ensure equitable access to modern treatments for public in line with global healthcare standards.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Pharmaceutical Companies Pharmaceutical Companies Health Insurance Companies 52

pharmaphorum

MAY 26, 2022

For example, with skin conditions, textbooks, studies, and trial photos often present lighter-skinned individuals’ symptoms, which are bound to differ in darker skinned individuals. Vaccines approved for public use require comprehensive RCTs to establish their safety and efficacy. The pandemic brought imbalances into sharp focus.

Packaging 143

Packaging Vaccines Generic Medicine Labelling 143

Pharmaceutical Technology

JULY 4, 2022

US President Joe Biden has gained approval from Congress for a new package of aid worth $40bn, and the US government announced last month that it plans to provide an additional $1bn in security assistance to Ukraine. million vaccine doses upon EMA authorisation.

Vaccines 122

Vaccines Packaging 122

RX Note

FEBRUARY 23, 2023

Threadworm - Night-time perianal itching is the classic presentation Oral Thrush - Unusual in healthy adults Faecal Incontinence - Unintentional passage of stool Pouching Systems - Available as one-piece or two-piece systems Eye Dry Eye - Evidence of superior efficacy among any of the ophthalmic lubricants is lacking.

HIV Treatment and Prevention Agents 58

HIV Treatment and Prevention Agents Community Pharmacies Labelling Chemotherapy 58

Pharmaceutical Technology

MARCH 22, 2023

You also need to create an attractive climate for the people that you want to have for these kinds of initiatives to want to locate and be present in the European Union.” The European Commission plans to launch its revised EU pharmaceutical package in Q1 2023 to ease drug shortages,” she says.

Pharmaceutical Manufacturing 105

Pharmaceutical Manufacturing Packaging Communication Diabetes 105

Pharmaceutical Technology

JANUARY 12, 2023

PM: Lyophilization is widely used in the pharmaceutical and biotech industry for small molecule drug products, vaccines, antibodies, and other biological material. That would not allow sufficient time to manufacture, package and distribute before half of the content was degraded. A great example is aspirin.

Packaging 52

Packaging Communication Vaccines 52

Express Pharma

NOVEMBER 28, 2024

Clariant Heath Care presented the company’s latest portfolio of products for the healthcare industry at CPHI India. VitiPure O 80 Superior and VitiPure L 20 Superior are additionally appropriate for the stabilisation of human and veterinary vaccines and biologics.

Vaccines 105

Vaccines Pharmaceutical Manufacturing Packaging Compounding 105